HEALTH: Why Did Drug Company Pfizer 'Keep Quiet' about Enbrel's Promising Potential in the Fight against Alzheimer's?

News Staff : Jun 5, 2019
MercuryNews.com

[Washington Post via Mercury News] "It would benefit the scientific community to have that data out there," said Keenan Walker, an assistant professor of medicine at Johns Hopkins who is studying how inflammation contributes to Alzheimer's. "Whether it was positive data or negative data, it gives us more information to make better informed decisions"... Subscribe for free to Breaking Christian News here Click here to read. (Image: Pixabay)